Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulation of PCSK9 and LDLR through DRP1 inhibition

Modulation of PCSK9 and LDLR through DRP1 inhibition

US Patent 10960020 · Granted Mar 30, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies blocking DLL4-mediated notch signalling2025
Materials and methods for extracellular vessicle-associated diseases2023
Materials and methods for extracellular vessicle-associated diseases2023
PARP9 and PARP14 as key regulators of macrophage activation2023
Method for inhibiting calcification of a smooth muscle cell (SMC)2022
Method for inhibiting calcification of a smooth muscle cell (SMC)2022
Notch inhibition in the treatment and prevention of nonalcoholic fatty liver dis2021
Notch inhibition in the treatment and prevention of nonalcoholic fatty liver dis2021
Method of inhibiting macrophage activation using an inhibitor of PARP92020
Sortilin 1 is a novel inducer of vascular calcification2019
Sortilin 1 is a novel inducer of vascular calcification2019
Mitochondrial phosphate carrier targets for treating soft-tissue calcification2019